Biotech company BrainBridge released a video demonstrating their AI “head transplant” system, an apparatus that can swap a human head onto a different body. They intend to perform the first surgery within this decade.
The video shows the machine carefully severing a human head and neck from the shoulders of a body that had become disabled and transplanting it onto a different, healthy human body. It would allegedly retain all the memories, brain processes and general consciousness of the individual in question.
The researchers hope to treat disease like Alzheimer’s and Parkinson’s, as well as various paralytic conditions and cancers.
🤖 BrainBridge, the first head transplant system, uses robotics and AI for head and face transplants, offering hope to those with severe conditions like stage-4 cancer and neurodegenerative diseases… pic.twitter.com/7qBYtdlVOo
— Tansu Yegen (@TansuYegen) May 21, 2024
The company calls itself “the world’s first revolutionary concept for head transplant system, employing cutting-edge robotics and artificial intelligence to ensure successful head and face transplantation procedures with improved outcomes and faster recoveries.”
“The process employs advanced high-speed robotic systems to prevent brain cell degradation and ensure seamless compatibility,” wrote BrainBridge in a statement. “The entire procedure is guided by real-time molecular-level imaging and AI algorithms to facilitate precise reconnection of the spinal cord, nerves, and blood vessels.”
It will be capable of executing “face and scalp transplantation to restore functionality” and even “aesthetic appearance,” noting the cosmetic benefits of the procedure: “Younger donor tissues reduce the risk of rejection and enhance appearance, with meticulous suturing and post-operative care to promote healing and minimize scarring.”
“The goal of our technology is to push the boundaries of what is possible in medical science and provide innovative solutions for those battling life-threatening conditions,” said Hashem Al-Ghaili, the scientist behind the initiative. “Our technology promises to open doors to lifesaving treatments that were unimaginable just a few years ago.”